JPMorgan downgraded Hologic (HOLX) to Neutral from Overweight with a $78 price target after the company agreed to be acquired by funds managed by Blackstone (BX) and TPG (TPG) in a transaction valued at up to $79 per share, representing an enterprise value of up to $18.3B.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HOLX:
- Hologic Stock (HOLX) Jumps as Blackstone and TPG Take It Private in $18B Deal
- Hold Rating on Hologic Amid Acquisition by Blackstone and TPG: Limited Impact on Diagnostics Sector
- Hologic price target raised to $78 from $70 at Leerink
- Midday Fly By: GM, Coca-Cola report Q3 beats
- Hologic downgraded to Market Perform from Outperform at William Blair